On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now


City View Green Holdings Inc. (CVGR) Sees Bright Future in Recreational Cannabis Products

  • Demand for recreational cannabis has outpaced supply in Canada
  • City View Green is retrofitting a 40,000-square-foot building to the highest standards for premium growth and extraction
  • The company has secured a master grower and expert extraction team to grow high-quality flower and produce superior-grade cannabis extracts

City View Green Holdings Inc. (CSE: CVGR) is a vertically integrated cannabis company focused on seed-to-retail offerings. The company’s goal is to be a leading purveyor of medicinal and recreational cannabis while providing the most comprehensive and customer-centric user experience and creating a well-diversified company capable of producing long-term results.

The demand for what CVGR offers within the recreational market in Canada alone has outpaced the supply. Only one month following legalization in Canada, consumers were warned to expect cannabis products to be sold out across the country (http://ibn.fm/O27o4). According to ArcView Market Research, the recreational market is estimated to be valued at $3 billion by 2021, achieving a projected compound annual growth rate of 78 percent from 2018 to 2021. Deloitte suggests that cannabis may outsell the combined beer, wine and spirits industry, while a potential economic impact of both medical and recreational is forecast to reach over $22 billion (http://ibn.fm/L2FoL).

CVGR is working within this quickly growing industry to help curate the cannabis experience for the recreational market consumer and provide guidance for established and new retailers. CVGR sees a strong future in recreational cannabis products and is positioned to produce high-quality edibles, distillates and water-soluble products for the beverage market. Having secured a master grower, the company will be growing a high-quality crop to create its own superior-grade cannabis extracts.

A 40,000-square-foot growing facility is in the planning stages in Brantford, Ontario. The property is being retrofitted to the highest standards for premium grow operations, which includes state-of-the-art LED lighting, HVAC, dehumidification systems and automation technologies. A 4,000-square-foot extraction lab will feature an ultra-efficient CO2 supercritical extraction process. The chosen supercritical fluid extraction equipment offers proven consistent results and the highest yields, with no degradation of materials.

“The equipment we have selected has been successfully used for a quarter century in fluid extraction, and their methods have been applied to over 600 natural oils and compounds from over 300 different bio-botanical raw materials,” Mike Hagopian, CVGR’s chief operations officer and extraction guru, stated in a news release. “We are very confident this equipment will establish us as a leader in the processing of high-quality THC and CBD extracts.”

While other companies focus mainly on crop yield, CVGR is also working to lower production costs while creating and refining extraction and processing methodologies. Utilizing the skill of a master grower and an expert extraction team, the company is focused on providing superior-grade cannabis products that utilize the entire plant, making the multitude of experiential and healing modalities that it offers readily available to consumers.

CVGR is focused on providing quality every step of the way. Utilizing premium growing operations and the highest-quality fluid extraction equipment, the company is committed to offering superior products to the consumer.

For more information, visit the company’s website at www.CityViewGreen.ca

NOTE TO INVESTORS: The latest news and updates relating to CVGR are available in the company’s newsroom at http://ibn.fm/CVGR

Last Tweets

Follow us: @Buy_Stocks_Now

From Our Blog

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) R&D Finds Lack of Adverse Chemical Byproducts in Manufacture of Drug Delivery Compositions

August 19, 2019

Lexaria Bioscience is involved in the research and improvement of its trademarked DehydraTECH technology, which enhances the bioavailability of some legal drug substances used by consumers The technology provides a rapid-on, rapid-off effect that may be effectively used in cannabis-infused edibles and beverages as an alternative to mind-altering substances such as alcohol and cannabis New […]

Rotate your device 90° to view site.